ZT Mining Launches Secure, High-Return Cloud Mining Solutions for Cryptocurrency Investors Worldwide
London, UK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- ZT Mining is becoming…
Calian to Hold Video Webcast Following Announcement of Fourth Quarter and FY 2024 Results
OTTAWA, Ontario, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (TSX:CGY),…
Introducing 4MYTU: Redefining the Modern Travel Experience with Functionality and Aesthetics
Denver, Colorado, Nov. 20, 2024 (GLOBE NEWSWIRE) -- As the demand for…
Availability of 2024-2025 Half-Year Financial Report
AVAILABILITY OF 2024-2025 HALF-YEAR FINANCIAL REPORT Bernin (Grenoble), France, on November 20,…
Rachel McAdams Joins ProSearch as Engagement Director in Dublin
LOS ANGELES, Nov. 20, 2024 (GLOBE NEWSWIRE) -- ProSearch, a leading provider…
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
-- SRC recommended that the trial escalate to the next dose level…
OXB to host a free webinar on accelerating development of viral vectors through automated manufacturing and analytical development
OXB to host a free webinar on accelerating development of viral vectors…
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 mg and Ezetimibe 10 mg in Patients with ASCVD or ASCVD Risk Factors and/or HeFH
-- Achieved all co-primary endpoints of LS mean reduction in LDL-C on…
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimers Disease
November 20, 2024 07:00 ET | Source: Voyager Therapeutics, Inc. - Candidate…
Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC and CBD Cultivars, Establishing a Key IP Pillar
Avextra Portugal launches an innovative in-house breeding program to develop proprietary cannabis…
